Measuring metacarpal cortical bone by digital x-ray radiogrammetry: A step forward?

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Geusens, Piet P ^a,b   Lems, Willem F ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DENOSUMAB; DICKKOPF 1 PROTEIN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; PREDNISONE;

ANTIBODY PRODUCTION; BONE BLOOD FLOW; BONE DENSITY; BONE EROSION; BONE RADIOGRAPHY; DIGITAL X RAY RADIOGRAMMETRY; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; HIGH RISK PATIENT; HUMAN; INFLAMMATION; METACARPAL BONE; OSTEOLYSIS; PREDICTOR VARIABLE; RHEUMATOID ARTHRITIS; NOTE; RADIOGRAPHY;

ARTHRITIS, RHEUMATOID; BONE DENSITY; HUMANS; METACARPAL BONES;

EID: 75649140934     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2788     Document Type: Editorial

References (11)

1. Bøyesen P, Hoff M, Odegård S, Haugeberg G, Syversen SW, Gaarder PI, Okkenhaug C, Kvien TK. Antibodies to cyclic citrillunated protein and ESR predict hand bone loss in patients with RA of short duration. Arthritis Res Ther 2009, 11:R103. 2745778, 19570223, 10.1186/ar2749.
2. Smolen JS, Aletaha D. Developments in the clinical understanding of rheumatoid arthritis. Arthritis Res Ther 2009, 11:204. 2688215, 19232060, 10.1186/ar2535.
3. Schett G. Bone marrow edema. Ann NY Acad Sci 2009, 1154:35-40. 10.1111/j.1749-6632.2009.04383.x, 19250229.
4. Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early RA: bone marrow edema predicts erosive progression. Ann Rheum Dis 2008, 67:794-800. 10.1136/ard.2007.071977, 17981915.
5. Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallée C, de Bois MH, Breedveld FC, Dijkmans BA, Lems WF. Changes in hand and generalised bone mineral density in patients with recent-onset RA. Ann Rheum Dis 2009, 68:330-336. 10.1136/ard.2007.086348, 18375540.
6. Schett G, Stach C, Zwerina J, Voll R, Manger B. How antirheumatic drugs protect joints from damage in RA. Arthritis Rheum 2008, 58:2936-2948. 10.1002/art.23951, 18821703.
7. Hoff M, Kvien TK, Kälvesten J, Elden A, Haugeberg G. Adalimumab therapy reduces hand bone loss on early RA. The PREMIER study. Ann Rheum Dis 2009, 68:1171-1176. 2689520, 18801760, 10.1136/ard.2008.091264.
8. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2008, 58:S126-135. 10.1002/art.23364, 18240203.
9. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, Heijde D, Zhou L, Tsuji W, Newmark R, . Denosumab Rheumatoid Arthritis Study Group Denosumab treatment effects on structural damage, BMD and bone turnover in RA: a 12-month, multicentre, randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum 2008, 58:1299-1309. 10.1002/art.23417, 18438830, Denosumab Rheumatoid Arthritis Study Group.
10. Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, Heijde DM, Linden S, Boers M. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006, 54:1772-1777. 10.1002/art.21896, 16736519.
11. Landewé R, Geusens P, Boers M, Heijde D, Lems W, te Koppele J, Linden S, Garnero P. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:1390-1399. 10.1002/art.20222, 15146408.